Evidence map›Paper›PMID 32330165›Full record

Observational studyPloS one2020

Implementing daily chlorhexidine gluconate treatment for the prevention of healthcare-associated infections in non-intensive care settings: A multiple case analysis.

Jackson S Musuuza, Tonya J Roberts, Ann Schoofs Hundt, Pascale Carayon, Michele L Zimbric, Valeri Schuetz, Mel Reppen, Windy Smith, Kirsten Koffarnus, Roger L Brown and 3 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06590675 (Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06590675 naterminatednot on this mapstarted 2025, after this paper: background citation

Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries

TypeinterventionalSponsorUniversity of PennsylvaniaRan2025 to 2025Enrolled19ConditionsMultidrug Resistant Bacterial InfectionArmsChlorhexidine Gluconate (CHG)
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jackson S MusuuzaDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America.ORCID 0000-0001-9447-7659
Tonya J RobertsWilliam S. Middleton Memorial Veterans Hospital, Madison, WI, United States of America.
Ann Schoofs HundtCenter for Quality and Productivity Improvement, Wisconsin Institute for Healthcare Systems Engineering, University of Wisconsin-Madison, Madison, WI, United States of America.
Pascale CarayonCenter for Quality and Productivity Improvement, Wisconsin Institute for Healthcare Systems Engineering, University of Wisconsin-Madison, Madison, WI, United States of America.ORCID 0000-0003-4632-6930
Michele L ZimbricDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America.ORCID 0000-0001-7344-3775
Valeri SchuetzSSM Health, St. Mary's Hospital, Madison, WI, United States of America.
Mel ReppenSSM Health, St. Mary's Hospital, Madison, WI, United States of America.
Windy SmithAmerican Family Children's Hospital, Madison, WI, United States of America.
Kirsten KoffarnusAmerican Family Children's Hospital, Madison, WI, United States of America.
Roger L BrownSchool of Nursing, University of Wisconsin-Madison, Madison, WI, United States of America.
Jason BowlingUniversity of Texas Health Science Center, San Antonio, TX, United States of America.
Kat JalaliUniversity of Texas Health Science Center, San Antonio, TX, United States of America.
Nasia SafdarDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States of America.
University of Wisconsin–Madison · USSt. Mary's Hospital · USThe University of Texas Health Science Center at San Antonio · USUniversity of Wisconsin American Family Children's Hospital · US

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Implementation of Chlorhexidine Bathing to Reduce Healthcare-Associated Infections-the Icare studyR18HS024039 · AHRQ · UNIVERSITY OF WISCONSIN-MADISON · PI SAFDAR, NASIA · 2015 to 2017
$1.5M
AHRQ HHS R18 HS024039NCATS NIH HHS UL1 TR002373
6 · The paper itself

Abstract

introductionDaily bathing with chlorhexidine gluconate (CHG) in hospitalized patients reduces healthcare-associated bloodstream infections and colonization by multidrug-resistant organisms. Achieving compliance with bathing protocols is challenging. This non-intensive care unit multicenter project evaluated the impact of organizational context on implementation of CHG and assessed compliance with and healthcare workers' perceptions of the intervention. MATERIALS AND

methodsThis was a multiple case study based on the SEIPS (Systems Engineering Initiative for Patient Safety) model of work system and patient safety. The four sites included an adult cardiovascular unit in a community hospital, a medical-surgical unit in an academic teaching pediatric hospital, an adult medical-surgical acute care unit and an adult neuroscience acute care unit in another academic teaching hospital. Complementary data collection methods included focus groups and interviews with healthcare workers (HCWs) and leaders, and direct observations of the CHG treatment process and skin swabs.

resultsWe collected 389 bathing observations and 110 skin swabs, conducted four focus groups with frontline workers and interviewed leaders. We found variation across cases in CHG compliance, skin swab data and implementation practices. Mean compliance with the bathing process ranged from 64% to 83%. Low detectable CHG on the skin was related to immediate rinsing of CHG from the skin. Variation in the implementation of CHG treatments was related to differences in organizational education and training practices, feedback and monitoring practices, patient education or information about CHG treatments, patient preferences and general unit patient population differences.

conclusionOrganizations planning to implement CHG treatments in non-ICU settings should ensure organizational readiness and buy-in and consider delivering systematic and ongoing training. Clear and systematic implementation policies across patients and units may help reduce potential confusion about treatment practices and variation across HCWs. Patient populations and unit factors need to be carefully considered and procedures developed to manage unique challenges.

Indexed as

AdultAnti-Infective Agents, LocalBathsChlorhexidineCritical CareCross InfectionFemaleHospitals, CommunityHumansIntensive Care UnitsMaleAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconate

Identifiers

PMID32330165
PMCPMC7182260
OpenAlexW3019660045

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.